These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
499 related items for PubMed ID: 21941216
21. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children]. Bao F, Qu JX, Liu ZJ, Qin XG, Cao B. Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804 [Abstract] [Full Text] [Related]
22. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y. Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374 [Abstract] [Full Text] [Related]
24. Evaluation of GENECUBE Mycoplasma for the detection of macrolide-resistant Mycoplasma pneumoniae. Morinaga Y, Suzuki H, Notake S, Mizusaka T, Uemura K, Otomo S, Oi Y, Ushiki A, Kawabata N, Kameyama K, Morishita E, Uekura Y, Sugiyama A, Kawashima Y, Yanagihara K. J Med Microbiol; 2020 Dec; 69(12):1346-1350. PubMed ID: 33141009 [Abstract] [Full Text] [Related]
25. First report of macrolide resistance in a Mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain. Caballero Jde D, del Campo R, Mafé Mdel C, Gálvez M, Rodríguez-Domínguez M, Cantón R, Meseguer MA, Hermida JM. Antimicrob Agents Chemother; 2014 Dec; 58(2):1265-6. PubMed ID: 24295969 [No Abstract] [Full Text] [Related]
26. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Lee H, Yun KW, Lee HJ, Choi EH. Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389 [Abstract] [Full Text] [Related]
27. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Kogoj R, Mrvic T, Praprotnik M, Kese D. Euro Surveill; 2015 Jan; 20(37):. PubMed ID: 26536357 [Abstract] [Full Text] [Related]
28. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, Kawamura N, Nakayama E, Tajima T, Shimizu K, Ubukata K. Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525 [Abstract] [Full Text] [Related]
29. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children. Lung DC, Yip EK, Lam DS, Que TL. Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339 [Abstract] [Full Text] [Related]
30. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, Okimoto N, Atypical Pathogen Study Group. BMC Infect Dis; 2012 May 31; 12():126. PubMed ID: 22650321 [Abstract] [Full Text] [Related]
32. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018. Zhao S, Musa SS, Qin J, He D. Int J Infect Dis; 2019 Apr 31; 81():251-253. PubMed ID: 30822543 [Abstract] [Full Text] [Related]
33. Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. Brown RJ, Macfarlane-Smith L, Phillips S, Chalker VJ. Euro Surveill; 2015 Apr 31; 20(48):30078. PubMed ID: 26675545 [Abstract] [Full Text] [Related]
34. Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia. Atkinson TP, Boppana S, Theos A, Clements LS, Xiao L, Waites K. Pediatrics; 2011 Jun 31; 127(6):e1605-9. PubMed ID: 21536614 [Abstract] [Full Text] [Related]
35. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report. Matsumoto M, Nagaoka K, Suzuki M, Konno S, Takahashi K, Takashina T, Ishiguro N, Nishimura M. BMC Infect Dis; 2019 Feb 28; 19(1):204. PubMed ID: 30819124 [Abstract] [Full Text] [Related]
36. Low Incidence of Macrolide-Resistant Mycoplasma pneumoniae between April 2016 and March 2017 in Akita Prefecture, Japan. Suzuki S, Konno T, Shibata C, Saito H. Jpn J Infect Dis; 2018 Nov 22; 71(6):477-478. PubMed ID: 30175736 [No Abstract] [Full Text] [Related]
37. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China. Zhao F, Lv M, Tao X, Huang H, Zhang B, Zhang Z, Zhang J. Antimicrob Agents Chemother; 2012 Feb 22; 56(2):1108-9. PubMed ID: 22106216 [Abstract] [Full Text] [Related]
38. [Macrolide-resistant Mycoplasma pneumoniae]. Morozumi M, Ubukata K. Nihon Rinsho; 2012 Feb 22; 70(2):251-5. PubMed ID: 22413527 [Abstract] [Full Text] [Related]
39. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. Kim YJ, Shin KS, Lee KH, Kim YR, Choi JH. J Korean Med Sci; 2017 Oct 22; 32(10):1642-1646. PubMed ID: 28875608 [Abstract] [Full Text] [Related]
40. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2. Ho PL, Law PY, Chan BW, Wong CW, To KK, Chiu SS, Cheng VC, Yam WC. J Clin Microbiol; 2015 Nov 22; 53(11):3560-4. PubMed ID: 26338857 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]